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A 45-year-old man with moderate renal impairment (serum
creatinine 1.5–2 mg/dl, CrCl 45–55 ml/min), proteinuria
(0.8–1.2 g/24 h), and severe thrombocytopenia (platelet count
10–30,000/mm3) was referred for outpatient nephrological
consultation. The patient was in good general condition,
working full time as a driver, with two sons in good health.
His medical history was notable for hypertension, which was
controlled by angiotensin-converting-enzyme inhibitors.
Kidney function impairment had been known since 2001.
Despite thrombocytopenia (since infancy), the patient had
never suffered from spontaneous bleeding.
The physical examination was unremarkable. Initial
diagnostic testing revealed no sign of autoimmune disease
(negative or normal: anti-nuclear antibody, anti-ENA anti-
body, anti–double-stranded DNA antibody, serum immuno-
globulins, complements, and C-reactive protein). Urine
microscopy was unremarkable. Mild metabolic acidosis (serum
HCO3 was 20 mEq/l) and mild increase of intact parathyroid
hormone (103 pg/ml) were present. Chest X-ray, electrocardio-
gram, and echocardiogram were normal, and renal ultrasound
revealed mildly hyperechogenic, normal-sized kidneys.
The patient was born from non-consanguineous parents,
both from a small southern Italian village; his father was
started on dialysis at 50 years of age; he is reported to have
had low platelet counts. Thrombocytopenia was reported on
his mother’s side as well (first-degree cousins, on regular
hematological follow-up in another town). The patient’s
brother suffered from moderate renal impairment and
thrombocytopenia.
The blood smear is shown in Figure 1.
What is your diagnosis?
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Figure 1 |Representative fields from the peripheral blood
smear of our patient (a and b). May-Gru¨nwald-Giemsa
staining. Bars¼ 10 nm.
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The Diagnosis | MYH9-related disease
The patient is affected by MYH9-related disease (MYH9-
RD), an autosomal dominant macrothrombocytopenia
variably associated with nephropathy, sensorineural deafness,
and presenile cataract.1–2 MYH9-RD encompasses four
different presentations previously known as May-Hegglin
anomaly, Sebastian syndrome, Fechtner syndrome, and
Epstein syndrome.1–3
MYH9 encodes for the heavy chain of the non-muscle
myosin IIA (NMMHC-IIA), a cytoplasmic myosin expressed
in most cells and tissues. In the kidney, NMMHC-IIA is
present in podocytes, mesangial, tubular, and endothelial
cells.1–2
MYH9-RD patients have thrombocytopenia and giant
platelets and develop one or more extra-hematological
manifestations during childhood or adulthood.
The peripheral blood smear shows thrombocytopenia and
marked platelet macrocytosis, with some platelets being equal
in size to or even larger than erythrocytes (‘giant platelets’;
Figure 1).
Granulocytes present ‘Do¨hle-like’ bodies: basophilic,
light-blue cytoplasmic inclusions, round or spindle shaped,
with major diameter of 2–7mm. ‘Do¨hle-like’ inclusions in
granulocytes are pathognomonic, although they are not
evident in 18–56% of affected subjects.1–2 Ophthalmologic
evaluation (normal in our patient) and audiometric testing
(which showed sensorineural hearing loss for high frequen-
cies 42000 Hz) may further refine the clinical hypothesis.
Kidney involvement is characterized by proteinuria,
microhematuria, and progression to renal failure.1–3 Renal
pathology has rarely been described, partly because throm-
bocytopenia limits the feasibility of renal biopsy. The most
frequently reported picture is focal segmental glomerulo-
sclerosis.1–3
In our patient, the family tree highlighted the association of
proteinuria, renal function impairment, and thrombocytopenia
in the patient’s brother, two male cousins, and one nephew.
The finding of chronic kidney disease and low platelets counts
on both mother’s and father’s side could be misleading, as
inheritance of MYH9-RD is autosomal dominant.
However, both parents came from an isolated, southern
Italian village, and an effect of a common ancestor can be
hypothesized. Indeed, clusters of autosomal dominant
diseases are not rare in such a setting.
The diagnostic suspicion is confirmed by immunofluor-
escence of the blood smears (Figure 2). The NMMHC-IIA
granulocyte aggregates are specific to MYH9-RD and are
recognizable in all patients with MYH9 mutations.1 Muta-
tional screening confirms the diagnosis and provides a
prognostic assessment. Our patient displayed the
c.4270G4C mutation in exon 30 (substitution of aspartic
acid at residue 1424 of the C-terminal domain of NMMHC-
IIA with histidine). According to the currently defined
genotype–phenotype relationships, he belongs to a subset of
cases with slow chronic kidney disease progression, who
benefit from support therapy including angiotensin-convert-
ing-enzyme inhibitors and/or angiotensin receptor blockers,
low protein diet, strict control of blood pressure, and
calcium–phosphate and acid–base balance.2–3
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Figure 2 | Immunofluorescence localization of non-muscle
myosin IIA (NMMHC-IIA) in blood smear granulocytes of the
reported patient. (a) The MYH9 protein is typically clustered
in evident cytoplasmic aggregates. (b) For comparison, a
granulocyte from a healthy subject shows normal, diffuse
cytoplasmic distribution of NMMHC-IIA. Bars¼ 10 nm.
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